AAIPharma, Xanodyne Pharmaceuticals deal

Xanodyne completed its previously announced purchase of AAIIQ's pharmaceutical assets to Xanodyne for $209.3 million in cash (see BioCentury, July 25). The acquired products include Darvon and Darvoce...